Per-Uno Malmström

Calendar time trends in synchronous metastatic urinary bladder cancer before and after the introduction of immune checkpoint inhibitors: a nation-wide population-based cohort study

Söderkvist, Karin; Häggström, Christel; Hagberg, Oskar; Aljabery, Firas et al.

Part of Frontiers in Oncology, 2025

• DOI for Calendar time trends in synchronous metastatic urinary bladder cancer before and after the introduction of immune checkpoint inhibitors: a nation-wide population-based cohort study
• Download full text (pdf) of Calendar time trends in synchronous metastatic urinary bladder cancer before and after the introduction of immune checkpoint inhibitors: a nation-wide population-based cohort study

Applicability of the European Association of Urology 2021 Prognostic Model for Non-muscle-invasive Bladder Cancer in a Swedish Population-based Cohort

Liedberg, Fredrik; Hagberg, Oskar; Beijert, Irene J.; Aljabery, Firas et al.

Part of European Urology Open Science, p. 33-37, 2025

• DOI for Applicability of the European Association of Urology 2021 Prognostic Model for Non-muscle-invasive Bladder Cancer in a Swedish Population-based Cohort
• Download full text (pdf) of Applicability of the European Association of Urology 2021 Prognostic Model for Non-muscle-invasive Bladder Cancer in a Swedish Population-based Cohort

Paradigm shift in the treatment of bladder cancer?: The Swedish perspective

Malmström, Per-Uno; Wang, Eugen Y. H.

Part of Scandinavian journal of urology, p. 186-188, 2025

• DOI for Paradigm shift in the treatment of bladder cancer?: The Swedish perspective
• Download full text (pdf) of Paradigm shift in the treatment of bladder cancer?: The Swedish perspective

Treatment Related to Urinary Tract Infections Is Associated with Delayed Diagnosis of Urinary Bladder Cancer: A Nationwide Population-based Study

Liedberg, Fredrik; Gardmark, Truls; Hagberg, Oskar; Aljabery, Firas et al.

Part of European Urology Oncology, p. 119-125, 2025

• DOI for Treatment Related to Urinary Tract Infections Is Associated with Delayed Diagnosis of Urinary Bladder Cancer: A Nationwide Population-based Study
• Download full text (pdf) of Treatment Related to Urinary Tract Infections Is Associated with Delayed Diagnosis of Urinary Bladder Cancer: A Nationwide Population-based Study

Comprehensive genomic characterization of early-stage bladder cancer

Prip, Frederik; Lamy, Philippe; Lindskrog, Sia Viborg; Strandgaard, Trine et al.

Part of Nature Genetics, p. 115-125, 2025

• DOI for Comprehensive genomic characterization of early-stage bladder cancer
• Download full text (pdf) of Comprehensive genomic characterization of early-stage bladder cancer

Calendar time trends in synchronous metastatic urinary bladder cancer before and after the introduction of immune checkpoint inhibitors: a nation-wide population-based cohort study

Söderkvist, Karin; Häggström, Christel; Hagberg, Oskar; Aljabery, Firas et al.

Part of Frontiers in Oncology, 2025

• DOI for Calendar time trends in synchronous metastatic urinary bladder cancer before and after the introduction of immune checkpoint inhibitors: a nation-wide population-based cohort study
• Download full text (pdf) of Calendar time trends in synchronous metastatic urinary bladder cancer before and after the introduction of immune checkpoint inhibitors: a nation-wide population-based cohort study

Applicability of the European Association of Urology 2021 Prognostic Model for Non-muscle-invasive Bladder Cancer in a Swedish Population-based Cohort

Liedberg, Fredrik; Hagberg, Oskar; Beijert, Irene J.; Aljabery, Firas et al.

Part of European Urology Open Science, p. 33-37, 2025

• DOI for Applicability of the European Association of Urology 2021 Prognostic Model for Non-muscle-invasive Bladder Cancer in a Swedish Population-based Cohort
• Download full text (pdf) of Applicability of the European Association of Urology 2021 Prognostic Model for Non-muscle-invasive Bladder Cancer in a Swedish Population-based Cohort

Paradigm shift in the treatment of bladder cancer?: The Swedish perspective

Malmström, Per-Uno; Wang, Eugen Y. H.

Part of Scandinavian journal of urology, p. 186-188, 2025

• DOI for Paradigm shift in the treatment of bladder cancer?: The Swedish perspective
• Download full text (pdf) of Paradigm shift in the treatment of bladder cancer?: The Swedish perspective

Treatment Related to Urinary Tract Infections Is Associated with Delayed Diagnosis of Urinary Bladder Cancer: A Nationwide Population-based Study

Liedberg, Fredrik; Gardmark, Truls; Hagberg, Oskar; Aljabery, Firas et al.

Part of European Urology Oncology, p. 119-125, 2025

• DOI for Treatment Related to Urinary Tract Infections Is Associated with Delayed Diagnosis of Urinary Bladder Cancer: A Nationwide Population-based Study
• Download full text (pdf) of Treatment Related to Urinary Tract Infections Is Associated with Delayed Diagnosis of Urinary Bladder Cancer: A Nationwide Population-based Study

Comprehensive genomic characterization of early-stage bladder cancer

Prip, Frederik; Lamy, Philippe; Lindskrog, Sia Viborg; Strandgaard, Trine et al.

Part of Nature Genetics, p. 115-125, 2025

• DOI for Comprehensive genomic characterization of early-stage bladder cancer
• Download full text (pdf) of Comprehensive genomic characterization of early-stage bladder cancer

The Swedish cooperation

Malmström, Per-Uno

Part of Urologic Oncology, p. 115-116, 2025

• DOI for The Swedish cooperation
• Download full text (pdf) of The Swedish cooperation

Cumulative incidence of and risk factors for BCG infection after adjuvant BCG instillations

Holmberg, Lars; Skogmar, Sten; Garmo, Hans; Hagberg, Oskar et al.

Part of BJU International, p. 229-238, 2024

• DOI for Cumulative incidence of and risk factors for BCG infection after adjuvant BCG instillations
• Download full text (pdf) of Cumulative incidence of and risk factors for BCG infection after adjuvant BCG instillations

Short term outcomes after robot assisted and open cystectomy- A nation-wide population-based study

Bergengren, Oskar; Belozerov, Alexej; Bill-Axelson, Anna; Garmo, Hans et al.

Part of European Journal of Surgical Oncology, p. 868-874, 2023

• DOI for Short term outcomes after robot assisted and open cystectomy- A nation-wide population-based study
• Download full text (pdf) of Short term outcomes after robot assisted and open cystectomy- A nation-wide population-based study

Elevated levels of MMP12 sourced from macrophages are associated with poor prognosis in urothelial bladder cancer

Kerzeli, Iliana Kyriaki; Kostakis, Alexandros; Türker, Polat; Malmström, Per-Uno et al.

Part of BMC Cancer, 2023

• DOI for Elevated levels of MMP12 sourced from macrophages are associated with poor prognosis in urothelial bladder cancer
• Download full text (pdf) of Elevated levels of MMP12 sourced from macrophages are associated with poor prognosis in urothelial bladder cancer

Abandoning testing for asymptomatic microscopic haematuria in Sweden - a long-term follow-up

Malmström, Per-Uno; Gårdmark, Truls

Part of Scandinavian journal of urology, p. 109-114, 2023

• DOI for Abandoning testing for asymptomatic microscopic haematuria in Sweden - a long-term follow-up
• Download full text (pdf) of Abandoning testing for asymptomatic microscopic haematuria in Sweden - a long-term follow-up

The association between BCG treatment in patients with bladder cancer and subsequent risk of developing Alzheimer and other dementia.: -A Swedish nationwide cohort study from 1997 to 2019

Wang, Eugen Y-H; Hagberg, Oskar; Malmström, Per-Uno

Part of PLOS ONE, 2023

• DOI for The association between BCG treatment in patients with bladder cancer and subsequent risk of developing Alzheimer and other dementia.: -A Swedish nationwide cohort study from 1997 to 2019
• Download full text (pdf) of The association between BCG treatment in patients with bladder cancer and subsequent risk of developing Alzheimer and other dementia.: -A Swedish nationwide cohort study from 1997 to 2019

An immune score reflecting pro- and anti-tumoural balance of tumour microenvironment has major prognostic impact and predicts immunotherapy response in solid cancers

Mezheyeuski, Artur; Backman, Max; Mattsson, Johanna Sofia Margareta; Martin-Bernabe, Alfonso et al.

Part of EBioMedicine, 2023

• DOI for An immune score reflecting pro- and anti-tumoural balance of tumour microenvironment has major prognostic impact and predicts immunotherapy response in solid cancers
• Download full text (pdf) of An immune score reflecting pro- and anti-tumoural balance of tumour microenvironment has major prognostic impact and predicts immunotherapy response in solid cancers

Nomograms including the UBC (R) Rapid test to detect primary bladder cancer based on a multicentre dataset

Meisl, Christina J.; Karakiewicz, Pierre; Einarsson, Roland; Koch, Stefan et al.

Part of BJU International, p. 754-763, 2022

• DOI for Nomograms including the UBC (R) Rapid test to detect primary bladder cancer based on a multicentre dataset

Cohort profile: Bladder Cancer Data Base Sweden (BladderBaSe) 2.0

Häggström, Christel; Hagberg, Oskar; Gardmark, Truls; Aljabery, Firas et al.

Part of BMJ Open, 2022

• DOI for Cohort profile: Bladder Cancer Data Base Sweden (BladderBaSe) 2.0
• Download full text (pdf) of Cohort profile: Bladder Cancer Data Base Sweden (BladderBaSe) 2.0

Number of transurethral procedures after non-muscle-invasive bladder cancer and survival in causes other than bladder cancer

Holmberg, Lars; Hagberg, Oskar; Häggström, Christel; Gårdmark, Truls et al.

Part of PLOS ONE, 2022

• DOI for Number of transurethral procedures after non-muscle-invasive bladder cancer and survival in causes other than bladder cancer
• Download full text (pdf) of Number of transurethral procedures after non-muscle-invasive bladder cancer and survival in causes other than bladder cancer

The cancer stigma: the importance of nomenclature

Malmström, Per-Uno

Part of Scandinavian journal of urology, p. 19-19, 2022

• DOI for The cancer stigma: the importance of nomenclature

Improved long-term outcome of patients with non-muscle invasive, low and intermediate risk bladder cancer between 1997 and 2014; a Swedish population-based study.

Wang, Eugen Y H; Pihlström, Nicklas; Malmström, Per-Uno; Gårdmark, Truls

Part of Scandinavian journal of urology, p. 221-226, 2022

• DOI for Improved long-term outcome of patients with non-muscle invasive, low and intermediate risk bladder cancer between 1997 and 2014; a Swedish population-based study.
• Download full text (pdf) of Improved long-term outcome of patients with non-muscle invasive, low and intermediate risk bladder cancer between 1997 and 2014; a Swedish population-based study.

PAI-1 is a potential transcriptional silencer that supports bladder cancer cell activity

Furuya, Hideki; Sasaki, Yuka; Chen, Runpu; Peres, Rafael et al.

Part of Scientific Reports, 2022

• DOI for PAI-1 is a potential transcriptional silencer that supports bladder cancer cell activity
• Download full text (pdf) of PAI-1 is a potential transcriptional silencer that supports bladder cancer cell activity

Risk factors for residual disease at re-TUR in a large cohort of T1G3 patients

Pisano, F.; Gontero, P.; Sylvester, R.; Joniau, S. et al.

Part of Actas Urológicas Españolas, p. 473-478, 2021

• DOI for Risk factors for residual disease at re-TUR in a large cohort of T1G3 patients

Survival after radical cystectomy during holiday periods

Liedberg, Fredrik; Hagberg, Oskar; Aljabery, Firas; Gårdmark, Truls et al.

Part of Scandinavian journal of urology, p. 276-280, 2021

• DOI for Survival after radical cystectomy during holiday periods
• Download full text (pdf) of Survival after radical cystectomy during holiday periods

Radical cystectomy compared to intravesical BCG immunotherapy for high-risk non-muscle invasive bladder cancer - is there a long-term survival difference?: A Swedish nationwide analysis

Wang, Eugen Y-H; Larsson, Ulf; Gårdmark, Truls; Malmström, Per-Uno

Part of Scandinavian journal of urology, p. 46-52, 2021

• DOI for Radical cystectomy compared to intravesical BCG immunotherapy for high-risk non-muscle invasive bladder cancer - is there a long-term survival difference?: A Swedish nationwide analysis

The new classification of urinary cytology - is it an improvement?

Hemdan, Tammer; Einarsson, Roland; Malmström, Per-Uno

Part of Scandinavian journal of urology, p. 98-99, 2021

• DOI for The new classification of urinary cytology - is it an improvement?

Combination of biomarkers for neoadjuvant systemic chemotherapy before cystectomy in patients with urinary bladder cancer

Turker, Polat; Wernroth, Mona-Lisa; Malmström, Per-Uno; Segersten, Ulrika et al.

Part of Translational Research, p. 77-84, 2021

• DOI for Combination of biomarkers for neoadjuvant systemic chemotherapy before cystectomy in patients with urinary bladder cancer

Association of patients' sex with treatment outcomes after intravesical bacillus Calmette-Guerin immunotherapy for T1G3/HG bladder cancer

D'Andrea, David; Soria, Francesco; Grotenhuis, Anne J.; Cha, Eugene K. et al.

Part of World journal of urology, p. 3337-3344, 2021

• DOI for Association of patients' sex with treatment outcomes after intravesical bacillus Calmette-Guerin immunotherapy for T1G3/HG bladder cancer
• Download full text (pdf) of Association of patients' sex with treatment outcomes after intravesical bacillus Calmette-Guerin immunotherapy for T1G3/HG bladder cancer

The diagnostic challenge of suspicious or positive malignant urine cytology findings when cystoscopy findings are normal: an outpatient blue-light flexible cystoscopy may solve the problem

Andersson, Marie; Berger, Marthe; Zieger, Karsten; Malmström, Per-Uno et al.

Part of Scandinavian journal of urology, p. 263-267, 2021

• DOI for The diagnostic challenge of suspicious or positive malignant urine cytology findings when cystoscopy findings are normal: an outpatient blue-light flexible cystoscopy may solve the problem

An integrated multi-omics analysis identifies prognostic molecular subtypes of non-muscle-invasive bladder cancer

Viborg Lindskrog, Sia; Prip, Frederik; Lamy, Philippe; Taber, Ann et al.

Part of Nature Communications, 2021

• DOI for An integrated multi-omics analysis identifies prognostic molecular subtypes of non-muscle-invasive bladder cancer
• Download full text (pdf) of An integrated multi-omics analysis identifies prognostic molecular subtypes of non-muscle-invasive bladder cancer

Single-cell RNAseq and longitudinal proteomic analysis of a novel semi-spontaneous urothelial cancer model reveals tumor cell heterogeneity and pretumoral urine protein alterations

Kerzeli, Iliana Kyriaki; Lord, Martin; Doroszko, Milena; Elgendy, Ramy et al.

Part of PLOS ONE, 2021

• DOI for Single-cell RNAseq and longitudinal proteomic analysis of a novel semi-spontaneous urothelial cancer model reveals tumor cell heterogeneity and pretumoral urine protein alterations
• Download full text (pdf) of Single-cell RNAseq and longitudinal proteomic analysis of a novel semi-spontaneous urothelial cancer model reveals tumor cell heterogeneity and pretumoral urine protein alterations

Proteomic comparison between different tissue preservation methods for identification of promising biomarkers of urothelial bladder cancer

Valdés, Alberto; Bitzios, Athanasios; Kassa, Eszter; Shevchenko, Ganna et al.

Part of Scientific Reports, 2021

• DOI for Proteomic comparison between different tissue preservation methods for identification of promising biomarkers of urothelial bladder cancer
• Download full text (pdf) of Proteomic comparison between different tissue preservation methods for identification of promising biomarkers of urothelial bladder cancer

Thromboembolism in Muscle-Invasive Bladder Cancer. A Population-based Nationwide Study

Jahnson, Staffan; Gårdmark, Truls; Hosseini, Abolfazl; Jerlström, Tomas et al.

Part of BLADDER CANCER, p. 161-171, 2021

• DOI for Thromboembolism in Muscle-Invasive Bladder Cancer. A Population-based Nationwide Study
• Download full text (pdf) of Thromboembolism in Muscle-Invasive Bladder Cancer. A Population-based Nationwide Study

The prognostic impact of the tumour stroma fraction: A machine learning-based analysis in 16 human solid tumour types

Micke, Patrick; Strell, Carina; Mattsson, Johanna Sofia Margareta; Martin-Bernabe, Alfonso et al.

Part of EBioMedicine, 2021

• DOI for The prognostic impact of the tumour stroma fraction: A machine learning-based analysis in 16 human solid tumour types
• Download full text (pdf) of The prognostic impact of the tumour stroma fraction: A machine learning-based analysis in 16 human solid tumour types

Treatment and prognosis of patients with urinary bladder cancer with other primary cancers: a nationwide population-based study in the Bladder Cancer Data Base Sweden (BladderBaSe).

Aljabery, Firas; Liedberg, Fredrik; Häggström, Christel; Ströck, Viveka et al.

Part of BJU International, p. 625-632, 2020

• DOI for Treatment and prognosis of patients with urinary bladder cancer with other primary cancers: a nationwide population-based study in the Bladder Cancer Data Base Sweden (BladderBaSe).
• Download full text (pdf) of Treatment and prognosis of patients with urinary bladder cancer with other primary cancers: a nationwide population-based study in the Bladder Cancer Data Base Sweden (BladderBaSe).

How to Treat Multifocal Ta High-grade Disease if Bacillus Calmette-Guerin Is Unavailable

Witjes, Johannes Alfred; Brausi, Maurizio; Malmström, Per-Uno

Part of European Urology Oncology, p. 705-709, 2020

• DOI for How to Treat Multifocal Ta High-grade Disease if Bacillus Calmette-Guerin Is Unavailable
• Download full text (pdf) of How to Treat Multifocal Ta High-grade Disease if Bacillus Calmette-Guerin Is Unavailable

No increased risk of short-term complications after radical cystectomy for muscle-invasive bladder cancer among patients treated with preoperative chemotherapy: a nation-wide register-based study.

Jerlström, Tomas; Chen, Ruoqing; Liedberg, Fredrik; Andrén, Ove et al.

Part of World journal of urology, p. 381-388, 2020

• DOI for No increased risk of short-term complications after radical cystectomy for muscle-invasive bladder cancer among patients treated with preoperative chemotherapy: a nation-wide register-based study.
• Download full text (pdf) of No increased risk of short-term complications after radical cystectomy for muscle-invasive bladder cancer among patients treated with preoperative chemotherapy: a nation-wide register-based study.

Cystoscopic surveillance of patients with non-muscle-invasive bladder cancer revisited.

Malmström, Per-Uno

Part of Scandinavian journal of urology, p. 364-366, 2020

• DOI for Cystoscopic surveillance of patients with non-muscle-invasive bladder cancer revisited.

Fibroblasts in urothelial bladder cancer define stroma phenotypes that are associated with clinical outcome

Mezheyeuski, Artur; Segersten, Ulrika; Leiss, Lina Wik; Malmström, Per-Uno et al.

Part of Scientific Reports, 2020

• DOI for Fibroblasts in urothelial bladder cancer define stroma phenotypes that are associated with clinical outcome
• Download full text (pdf) of Fibroblasts in urothelial bladder cancer define stroma phenotypes that are associated with clinical outcome

Survival after radiotherapy versus radical cystectomy for primary muscle-invasive bladder cancer: A Swedish nationwide population-based cohort study

Häggström, Christel; Garmo, Hans; de Luna, Xavier; Van Hemelrijck, Mieke et al.

Part of Cancer Medicine, p. 2196-2204, 2019

• DOI for Survival after radiotherapy versus radical cystectomy for primary muscle-invasive bladder cancer: A Swedish nationwide population-based cohort study
• Download full text (pdf) of Survival after radiotherapy versus radical cystectomy for primary muscle-invasive bladder cancer: A Swedish nationwide population-based cohort study

Is Bcl-2 a predictive marker of neoadjuvant chemotherapy response in patients with urothelial bladder cancer undergoing radical cystectomy?

Turker, Polat; Segersten, Ulrika; Malmström, Per-Uno; Hemdan, Tammer

Part of Scandinavian journal of urology, p. 45-50, 2019

• DOI for Is Bcl-2 a predictive marker of neoadjuvant chemotherapy response in patients with urothelial bladder cancer undergoing radical cystectomy?
• Download full text (pdf) of Is Bcl-2 a predictive marker of neoadjuvant chemotherapy response in patients with urothelial bladder cancer undergoing radical cystectomy?

Recurrent Ta Low-grade Non-muscle-invasive Bladder Cancer: What Are the Options?

Roupret, Morgan; Malmström, Per-Uno; Black, Peter

Part of European Urology Oncology, p. 723-729, 2019

• DOI for Recurrent Ta Low-grade Non-muscle-invasive Bladder Cancer: What Are the Options?
• Download full text (pdf) of Recurrent Ta Low-grade Non-muscle-invasive Bladder Cancer: What Are the Options?

A Nationwide, Population Based Analysis of Patients with Organ Confined, Muscle Invasive Bladder Cancer Not Receiving Curative Intent Therapy in Sweden from 1997 to 2014

Westergren, Dan-Olle; Gardmark, Truls; Lindhagen, Lars; Chau, Albert et al.

Part of Journal of Urology, p. 905-912, 2019

• DOI for A Nationwide, Population Based Analysis of Patients with Organ Confined, Muscle Invasive Bladder Cancer Not Receiving Curative Intent Therapy in Sweden from 1997 to 2014

Management and outcome of TaG3 tumours of the urinary bladder in the nationwide, population-based bladder cancer database Sweden (BladderBaSe)

Jahnson, Staffan; Gårdmark, Truls; Hosseini, Abolfazl; Jedström, Tomas et al.

Part of Scandinavian journal of urology, p. 200-205, 2019

• DOI for Management and outcome of TaG3 tumours of the urinary bladder in the nationwide, population-based bladder cancer database Sweden (BladderBaSe)

Period-specific mean annual hospital volume of radical cystectomy is associated with outcome and perioperative quality of care: a nationwide population-based study

Liedberg, Fredrik; Hagberg, Oskar; Aljabery, Firas; Gardmark, Truls et al.

Part of BJU International, p. 449-456, 2019

• DOI for Period-specific mean annual hospital volume of radical cystectomy is associated with outcome and perioperative quality of care: a nationwide population-based study

Neoadjuvant chemotherapy for muscle invasive bladder cancer: a nationwide investigation on survival

Russell, Beth; Sherif, Amir; Häggström, Christel; Josephs, Debra et al.

Part of Scandinavian journal of urology, p. 206-212, 2019

• DOI for Neoadjuvant chemotherapy for muscle invasive bladder cancer: a nationwide investigation on survival

Incidence, survival and mortality trends of bladder cancer in Sweden 1997-2016

Malmström, Per-Uno; Gårdmark, Truls; Sherif, Amir; Ströck, Viveka et al.

Part of Scandinavian journal of urology, p. 193-199, 2019

• DOI for Incidence, survival and mortality trends of bladder cancer in Sweden 1997-2016

Progress towards a Nordic standard for the investigation of hematuria

Malmström, Per-Uno; Skaaheim, Erik; Boström, Peter J.; Gudjonsson, Sigidur et al.

Part of Scandinavian journal of urology, p. 1-6, 2019

• DOI for Progress towards a Nordic standard for the investigation of hematuria
• Download full text (pdf) of Progress towards a Nordic standard for the investigation of hematuria

Bladder health in patients treated with BCG instillations for T1G2-G3 bladder cancer - a follow-up five years after the start of treatment

Danielsson, Gun; Malmström, Per-Uno; Jahnson, Staffan; Wijkström, Hans et al.

Part of Scandinavian journal of urology, p. 377-384, 2018

• DOI for Bladder health in patients treated with BCG instillations for T1G2-G3 bladder cancer - a follow-up five years after the start of treatment

Molecular Markers Increase Precision of the European Association of Urology Non-Muscle-Invasive Bladder Cancer Progression Risk Groups

van Kessel, Kim E. M.; van der Keur, Kirstin A.; Dyrskjot, Lars; Algaba, Ferran et al.

Part of Clinical Cancer Research, p. 1586-1593, 2018

• DOI for Molecular Markers Increase Precision of the European Association of Urology Non-Muscle-Invasive Bladder Cancer Progression Risk Groups

Recurrence, progression and cancer-specific mortality according to stage at re-TUR in T1G3 bladder cancer patients treated with BCG: not as bad as previously thought

Palou, J.; Pisano, F.; Sylvester, R.; Joniau, S. et al.

Part of World journal of urology, p. 1621-1627, 2018

• DOI for Recurrence, progression and cancer-specific mortality according to stage at re-TUR in T1G3 bladder cancer patients treated with BCG: not as bad as previously thought

Predictors of oncological outcomes in T1G3 patients treated with BCG who undergo radical cystectomy

Soria, Francesco; Pisano, Francesca; Gontero, Paolo; Palou, J. et al.

Part of World journal of urology, p. 1775-1781, 2018

• DOI for Predictors of oncological outcomes in T1G3 patients treated with BCG who undergo radical cystectomy

Can routine outpatient follow-up of patients with bladder cancer be improved?: A multicenter prospective observational assessment of blue light flexible cystoscopy and fulguration

Zare, Reza; Grabe, Magnus; Hermann, Gregers G.; Malmström, Per-Uno

Part of Research and Reports in Urology, p. 151-157, 2018

• DOI for Can routine outpatient follow-up of patients with bladder cancer be improved?: A multicenter prospective observational assessment of blue light flexible cystoscopy and fulguration
• Download full text (pdf) of Can routine outpatient follow-up of patients with bladder cancer be improved?: A multicenter prospective observational assessment of blue light flexible cystoscopy and fulguration

Choline-phosphate cytidylyltransferase-alpha as a possible predictor of survival and response to cisplatin neoadjuvant chemotherapy in urothelial cancer of the bladder

Hemdan, Tammer; Turker, Polat; Malmström, Per-Uno; Segersten, Ulrika

Part of Scandinavian journal of urology, p. 200-205, 2018

• DOI for Choline-phosphate cytidylyltransferase-alpha as a possible predictor of survival and response to cisplatin neoadjuvant chemotherapy in urothelial cancer of the bladder
• Download full text (pdf) of Choline-phosphate cytidylyltransferase-alpha as a possible predictor of survival and response to cisplatin neoadjuvant chemotherapy in urothelial cancer of the bladder

Treatment according to guidelines may bridge the gender gap in outcome for patients with stage T1 urinary bladder cancer

Sjostrom, Carin; Thorstenson, Andreas; Strock, Viveka; Hosseini-Aliabad, Abolfazl et al.

Part of Scandinavian journal of urology, p. 186-193, 2018

• DOI for Treatment according to guidelines may bridge the gender gap in outcome for patients with stage T1 urinary bladder cancer

Parallel Proteomic Workflow for Mass Spectrometric Analysis of Tissue Samples Preserved by Different Methods

Holfeld, Aleš; Valdés, Alberto; Malmström, Per-Uno; Segersten, Ulrika et al.

Part of Analytical Chemistry, p. 5841-5849, 2018

• DOI for Parallel Proteomic Workflow for Mass Spectrometric Analysis of Tissue Samples Preserved by Different Methods

Validation of a DNA Methylation-Mutation Urine Assay to Select Patients with Hematuria for Cystoscopy

van Kessel, Kim E. M.; Beukers, Willemien; Lurkin, Irene; Ziel-van der Made, Angelique et al.

Part of Journal of Urology, p. 590-595, 2017

• DOI for Validation of a DNA Methylation-Mutation Urine Assay to Select Patients with Hematuria for Cystoscopy

Significantly more downstaging in patients recieving preoperative (neoadjuvant and induction) chemotherapy prior to cystectomy for muscle-invasive bladder cancer

Jerlstrom, Tomas; Gardmark, Truls; Strock, Viveka; Aljabery, Firas A. -S. et al.

Part of Scandinavian journal of urology, p. 34-35, 2017

• DOI for Significantly more downstaging in patients recieving preoperative (neoadjuvant and induction) chemotherapy prior to cystectomy for muscle-invasive bladder cancer

Intravesical instillations and cancer-specific survival in patients with primary carcinoma in situ of the urinary bladder

Jancke, Georg; Liedberg, Fredrik; Aljabery, Firas; Sherif, Amir et al.

Part of Scandinavian journal of urology, p. 124-129, 2017

• DOI for Intravesical instillations and cancer-specific survival in patients with primary carcinoma in situ of the urinary bladder

Prognostic Impact of a 12-gene Progression Score in Non-muscle-invasive Bladder Cancer: A Prospective Multicentre Validation Study

Dyrskjot, Lars; Reinert, Thomas; Algaba, Ferran; Christensen, Emil et al.

Part of European Urology, p. 461-469, 2017

• DOI for Prognostic Impact of a 12-gene Progression Score in Non-muscle-invasive Bladder Cancer: A Prospective Multicentre Validation Study

Evaluation of the diagnostic accuracy of UBC^® Rapid in bladder cancer: a Swedish multicentre study

Styrke, Johan; Henriksson, Helene; Ljungberg, Borje; Hasan, Mudhar et al.

Part of Scandinavian journal of urology, p. 293-300, 2017

• DOI for Evaluation of the diagnostic accuracy of UBC^® Rapid in bladder cancer: a Swedish multicentre study

Second-look resection for primary stage T1 bladder cancer: a population-based study

Patschan, Oliver; Holmang, Sten; Hosseini, Abolfazl; Jancke, Georg et al.

Part of Scandinavian journal of urology, p. 301-307, 2017

• DOI for Second-look resection for primary stage T1 bladder cancer: a population-based study

Drugs and risk of cancer

Malmström, Per-Uno

Part of Scandinavian journal of urology, p. 212-212, 2017

• DOI for Drugs and risk of cancer

Evidence in Urologic- and Pelvic-Surgery Research: Finding the IDEAL Way of Reporting

Gerullis, H.; Barski, D.; Malmström, Per-Uno; Sun, X. et al.

Part of BioMed Research International, 2017

• DOI for Evidence in Urologic- and Pelvic-Surgery Research: Finding the IDEAL Way of Reporting
• Download full text (pdf) of Evidence in Urologic- and Pelvic-Surgery Research: Finding the IDEAL Way of Reporting

Half a decade of fluorescence in the bladder

Malmström, Per-Uno

Part of Scandinavian journal of urology, p. 219-219, 2017

• DOI for Half a decade of fluorescence in the bladder

Scientific breakthrough or "fake news"?

Malmström, Per-Uno

Part of Scandinavian journal of urology, p. 177-177, 2017

• DOI for Scientific breakthrough or "fake news"?

Validation of the ezrin, CK20, and Ki-67 as potential predictive markers for BCG instillation therapy of non-muscle-invasive bladder cancer

Malmström, Per-Uno; Hemdan, Tammer; Segersten, Ulrika

Part of Urologic Oncology, p. 5320-532000000, 2017

• DOI for Validation of the ezrin, CK20, and Ki-67 as potential predictive markers for BCG instillation therapy of non-muscle-invasive bladder cancer

FGFR3, TERT and OTX1 as a Urinary Biomarker Combination for Surveillance of Patients with Bladder Cancer in a Large Prospective Multicenter Study

Beukers, Willemien; van der Keur, Kirstin A.; Kandimalla, Raju; Vergouwe, Yvonne et al.

Part of Journal of Urology, p. 1410-1418, 2017

• DOI for FGFR3, TERT and OTX1 as a Urinary Biomarker Combination for Surveillance of Patients with Bladder Cancer in a Large Prospective Multicenter Study

Association of MMP-2, RB and PAI-1 with decreased recurrence-free survival and overall survival in bladder cancer patients

Chan, Owen T. M.; Furuya, Hideki; Pagano, Ian; Shimizu, Yoshiko et al.

Part of Oncotarget, p. 99707-99721, 2017

• DOI for Association of MMP-2, RB and PAI-1 with decreased recurrence-free survival and overall survival in bladder cancer patients
• Download full text (pdf) of Association of MMP-2, RB and PAI-1 with decreased recurrence-free survival and overall survival in bladder cancer patients

Cohort profile: The Swedish National Register of Urinary Bladder Cancer (SNRUBC) and the Bladder Cancer Data Base Sweden (BladderBaSe)

Häggström, Christel; Liedberg, Fredrik; Hagberg, Oskar; Aljabery, Firas et al.

Part of BMJ Open, 2017

• DOI for Cohort profile: The Swedish National Register of Urinary Bladder Cancer (SNRUBC) and the Bladder Cancer Data Base Sweden (BladderBaSe)
• Download full text (pdf) of Cohort profile: The Swedish National Register of Urinary Bladder Cancer (SNRUBC) and the Bladder Cancer Data Base Sweden (BladderBaSe)

Seventeen-year follow-up of the prospective randomized Nordic CIS study: BCG monotherapy versus alternating therapy with mitomycin C and BCG in patients with carcinoma in situ of the urinary bladder

Kaasinen, Eero; Wijkström, Hans; Rintala, Erkki; Mestad, Oddvar et al.

Part of Scandinavian journal of urology, p. 360-368, 2016

• DOI for Seventeen-year follow-up of the prospective randomized Nordic CIS study: BCG monotherapy versus alternating therapy with mitomycin C and BCG in patients with carcinoma in situ of the urinary bladder

The impact of re-transurethral resection on clinical outcomes in a large multicentre cohort of patients with T1 high-grade/Grade 3 bladder cancer treated with bacille Calmette-Guérin

Gontero, Paolo; Sylvester, Richard; Pisano, Francesca; Joniau, Steven et al.

Part of BJU International, p. 44-52, 2016

• DOI for The impact of re-transurethral resection on clinical outcomes in a large multicentre cohort of patients with T1 high-grade/Grade 3 bladder cancer treated with bacille Calmette-Guérin

The efficacy of BCG TICE and BCG Connaught in a cohort of 2,099 patients with T1G3 non-muscle-invasive bladder cancer

Witjes, J Alfred; Dalbagni, Guido; Karnes, Robert J; Shariat, Shahrokh et al.

Part of Urologic Oncology, 2016

• DOI for The efficacy of BCG TICE and BCG Connaught in a cohort of 2,099 patients with T1G3 non-muscle-invasive bladder cancer

Comprehensive Transcriptional Analysis of Early-Stage Urothelial Carcinoma

Hedegaard, Jakob; Lamy, Philippe; Nordentoft, Iver; Algaba, Ferran et al.

Part of Cancer Cell, p. 27-42, 2016

• DOI for Comprehensive Transcriptional Analysis of Early-Stage Urothelial Carcinoma

Swedish National Registry of Urinary Bladder Cancer: No difference in relative survival over time despite more aggressive treatment.

Jahnson, Staffan; Hosseini Aliabad, Abolfazl; Holmäng, Sten; Jancke, Georg et al.

Part of Scandinavian journal of urology, p. 14-20, 2016

• DOI for Swedish National Registry of Urinary Bladder Cancer: No difference in relative survival over time despite more aggressive treatment.

Budget impact of incorporating one instillation of hexaminolevulinate hydrochloride blue-light cytoscopy in transurethral bladder tumour resection for patients with non-muscle-invasive bladder cancer in Sweden.

Rose, James B; Armstrong, Shannon; Hermann, Gregers G; Kjellberg, Jakob et al.

Part of BJU International, 2016

• DOI for Budget impact of incorporating one instillation of hexaminolevulinate hydrochloride blue-light cytoscopy in transurethral bladder tumour resection for patients with non-muscle-invasive bladder cancer in Sweden.

Gender-related differences in urothelial carcinoma of the bladder: a population-based study from the Swedish National Registry of Urinary Bladder Cancer

Thorstenson, Andreas; Hagberg, Oskar; Ljungberg, Borje; Liedberg, Fredrik et al.

Part of Scandinavian journal of urology, p. 292-297, 2016

• DOI for Gender-related differences in urothelial carcinoma of the bladder: a population-based study from the Swedish National Registry of Urinary Bladder Cancer

Hexaminolevulinate hydrochloride blue-light flexible cystoscopy in the detection and follow-up of nonmuscle-invasive bladder cancer: cost consequences during outpatient surveillance in Sweden

Dansk, Viktor; Malmstrom, Per-Uno; Blackberg, Mats; Malmenas, Maria

Part of Future Oncology, p. 1025-1038, 2016

• DOI for Hexaminolevulinate hydrochloride blue-light flexible cystoscopy in the detection and follow-up of nonmuscle-invasive bladder cancer: cost consequences during outpatient surveillance in Sweden

Re: Richard J. Sylvester, Willem Oosterlinck, Sten Holmang, et al. Systematic Review and Individual Patient Data Meta-analysis of Randomized Trials Comparing a Single Immediate Instillation of Chemotherapy After Transurethral Resection with Transurethral Resection Alone in Patients with Stage pTa-pT1 Urothelial Carcinoma of the Bladder: Which Patients Benefit from the Instillation? Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2015.05.050

Malmström, Per-Uno; Trock, Bruce J.

Part of European Urology, 2015

• DOI for Re: Richard J. Sylvester, Willem Oosterlinck, Sten Holmang, et al. Systematic Review and Individual Patient Data Meta-analysis of Randomized Trials Comparing a Single Immediate Instillation of Chemotherapy After Transurethral Resection with Transurethral Resection Alone in Patients with Stage pTa-pT1 Urothelial Carcinoma of the Bladder: Which Patients Benefit from the Instillation? Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2015.05.050

Emmprin Expression Predicts Response and Survival following Cisplatin Containing Chemotherapy for Bladder Cancer: A Validation Study.

Hemdan, Tammer; Malmström, Per-Uno; Jahnson, Staffan; Segersten, Ulrika

Part of Journal of Urology, p. 1575-1581, 2015

• DOI for Emmprin Expression Predicts Response and Survival following Cisplatin Containing Chemotherapy for Bladder Cancer: A Validation Study.

Prognostic Factors and Risk Groups in T1G3 Non-Muscle-invasive Bladder Cancer Patients Initially Treated with Bacillus Calmette-Guerin: Results of a Retrospective Multicenter Study of 2451 Patients

Gontero, Paolo; Sylvester, Richard; Pisano, Francesca; Joniau, Steven et al.

Part of European Urology, p. 74-82, 2015

• DOI for Prognostic Factors and Risk Groups in T1G3 Non-Muscle-invasive Bladder Cancer Patients Initially Treated with Bacillus Calmette-Guerin: Results of a Retrospective Multicenter Study of 2451 Patients

Local recurrence and progression of non-muscle-invasive bladder cancer in Sweden: a population-based follow-up study

Liedberg, Fredrik; Hagberg, Oskar; Holmang, Sten; Aliabad, Abolfazl Hosseini et al.

Part of Scandinavian journal of urology, p. 290-295, 2015

• DOI for Local recurrence and progression of non-muscle-invasive bladder cancer in Sweden: a population-based follow-up study

Use of bacillus Calmette-Guérin in stage T1 bladder cancer: Long-term observation of a population-based cohort

Patschan, Oliver; Holmäng, Sten; Hosseini, Abolfazl; Liedberg, Fredrik et al.

Part of Scandinavian journal of urology, p. 127-132, 2015

• DOI for Use of bacillus Calmette-Guérin in stage T1 bladder cancer: Long-term observation of a population-based cohort

How do we acquire high-level evidence in urology? A 30 year perspective

Malmström, Per-Uno

Part of Scandinavian journal of urology, p. 1-1, 2015

• DOI for How do we acquire high-level evidence in urology? A 30 year perspective

EGFR-expression in primary urinary bladder cancer and corresponding metastases and the relation to HER2-expression. On the possibility to target these receptors with radionuclides

Carlsson, Jörgen; Wester, Kenneth; De La Torre, Manuel; Malmström, Per-Uno et al.

Part of Radiology and Oncology, p. 50-58, 2015

• DOI for EGFR-expression in primary urinary bladder cancer and corresponding metastases and the relation to HER2-expression. On the possibility to target these receptors with radionuclides

A urine based assay to select patients for initial cystoscopy

van Kessel, Kim E. M.; Beukers, Willemien; Lurkin, Irene; van der Keur, Kirstin A. et al.

Part of Cancer Research, 2015

• DOI for A urine based assay to select patients for initial cystoscopy

Hematurispåret – en väg att snabbare diagnostisera blåscancer

Gunnarsson, Jonas; Dahlman, Pär; Helenius, Malin; Liss, Per et al.

Part of Svensk Urologi, p. 38, 2015

The role of microRNA profiling in prognosticating progression in Ta and T1 urinary bladder cancer

Segersten, Ulrika; Spector, Yael; Goren, Yaron; Tabak, Sarit et al.

Part of Urologic Oncology, p. 613-618, 2014

• DOI for The role of microRNA profiling in prognosticating progression in Ta and T1 urinary bladder cancer

Reduced expression of ezrin in urothelial bladder cancer signifies more advanced tumours and an impaired survival: validatory study of two independent patient cohorts

Andersson, Gustav; Wennersten, Christoffer; Gaber, Alexander; Boman, Karolina et al.

Part of BMC Urology, p. 36, 2014

• DOI for Reduced expression of ezrin in urothelial bladder cancer signifies more advanced tumours and an impaired survival: validatory study of two independent patient cohorts
• Download full text (pdf) of Reduced expression of ezrin in urothelial bladder cancer signifies more advanced tumours and an impaired survival: validatory study of two independent patient cohorts

Urinary bladder cancer treated with radical cystectomy: Perioperative parameters and early complications prospectively registered in a national population-based database

Jerlstrom, Tomas; Gardmark, Truls; Carringer, Malcolm; Holmang, Sten et al.

Part of Scandinavian journal of urology, p. 334-340, 2014

• DOI for Urinary bladder cancer treated with radical cystectomy: Perioperative parameters and early complications prospectively registered in a national population-based database

Risk Prediction Scores for Recurrence and Progression of Non-Muscle Invasive Bladder Cancer: An International Validation in Primary Tumours

Vedder, Moniek M.; Marquez, Mirari; de Bekker-Grob, Esther W.; Calle, Malu L. et al.

Part of PLOS ONE, 2014

• DOI for Risk Prediction Scores for Recurrence and Progression of Non-Muscle Invasive Bladder Cancer: An International Validation in Primary Tumours
• Download full text (pdf) of Risk Prediction Scores for Recurrence and Progression of Non-Muscle Invasive Bladder Cancer: An International Validation in Primary Tumours

Five year outcome of a randomized prospective study comparing bacillus Calmette-Guerin with epirubicin and interferon α 2b in patients with T1 bladder cancer

Hemdan, Tammer; Johansson, Robert; Jahnson, Staffan; Hellström, Pekka et al.

Part of Journal of Urology, p. 1244-1249, 2014

• DOI for Five year outcome of a randomized prospective study comparing bacillus Calmette-Guerin with epirubicin and interferon α 2b in patients with T1 bladder cancer

"To Improve Is To Change; To Be Perfect Is To Change Often"

Malmström, Per-Uno

Part of European Urology, p. 358-359, 2014

• DOI for "To Improve Is To Change; To Be Perfect Is To Change Often"

The prognostic value and therapeutic target role of stathmin-1 in urinary bladder cancer

Hemdan, Tammer; Lindén, Mårten; Lind, Sara; Namuduri, Arvind et al.

Part of British Journal of Cancer, p. 1180-1187, 2014

• DOI for The prognostic value and therapeutic target role of stathmin-1 in urinary bladder cancer
• Download full text (pdf) of The prognostic value and therapeutic target role of stathmin-1 in urinary bladder cancer

Decreased expression of RNA-binding motif protein 3 correlates with tumour progression and poor prognosis in urothelial bladder cancer

Boman, Karolina; Segersten, Ulrika; Ahlgren, Göran; Eberhard, Jakob et al.

Part of BMC Urology, p. 17, 2013

• DOI for Decreased expression of RNA-binding motif protein 3 correlates with tumour progression and poor prognosis in urothelial bladder cancer
• Download full text (pdf) of Decreased expression of RNA-binding motif protein 3 correlates with tumour progression and poor prognosis in urothelial bladder cancer

Tumour expression of bladder cancer-associated urinary proteins

Lindén, Mårten; Segersten, Ulrika; Runeson, Marcus; Wester, Kenneth et al.

Part of BJU International, p. 407-415, 2013

• DOI for Tumour expression of bladder cancer-associated urinary proteins

Multicenter Validation of Cyclin D1, MCM7, TRIM29, and UBE2C as Prognostic Protein Markers in Non-Muscle Invasive Bladder Cancer

Fristrup, Niels; Birkenkamp-Demtröder, Karin; Reinert, Thomas; Sanchez-Carbayo, Marta et al.

Part of American Journal of Pathology, p. 339-349, 2013

• DOI for Multicenter Validation of Cyclin D1, MCM7, TRIM29, and UBE2C as Prognostic Protein Markers in Non-Muscle Invasive Bladder Cancer

Membranous expression of podocalyxin-like protein is an independent factor of poor prognosis in urothelial bladder cancer

Boman, K; Larsson, A H; Segersten, Ulrika; Kuteeva, E et al.

Part of British Journal of Cancer, p. 2321-2328, 2013

• DOI for Membranous expression of podocalyxin-like protein is an independent factor of poor prognosis in urothelial bladder cancer

Prognostic Factors And Risk Groups In T1g3 Patients Initially Treated With Bcg: Results Of A Multicenter Retrospective Series In 1743 Patients

Gonterol, P.; Sylvester, R.; Pisano, F.; Joniau, S. et al.

Part of Anticancer Research, p. 2260-2261, 2013

Impact of hospital volume on local recurrence and distant metastasis in bladder cancer patients treated with radical cystectomy in Sweden

Sabir, Emad F; Holmäng, Sten; Liedberg, Fredrik; Ljungberg, Börje et al.

Part of Scandinavian journal of urology, p. 483-490, 2013

• DOI for Impact of hospital volume on local recurrence and distant metastasis in bladder cancer patients treated with radical cystectomy in Sweden

Five-year results of nordic T1G2-3, a randomized trial comparing bcg with epirubicin and interferon alpha 2b

Hemdan, Tammer; Johansson, Robert; Jahnson, Staffan; Hellstrom, Pekka et al.

Part of SCANDINAVIAN JOURNAL OF UROLOGY, p. 19-20, 2013

Editorial

Malmström, Per-Uno

Part of Scandinavian journal of urology, p. 3-3, 2013

• DOI for Editorial

Proteomic analysis of urinary biomarker candidates for nonmuscle invasive bladder cancer

Lindén, Mårten; Lind, Sara Bergström; Mayrhofer, Corina; Segersten, Ulrika et al.

Part of Proteomics, p. 135-144, 2012

• DOI for Proteomic analysis of urinary biomarker candidates for nonmuscle invasive bladder cancer

Role of hexaminolevulinate-guided fluorescence cystoscopy in bladder cancer: critical analysis of the latest data and European guidance

Malmström, Per-Uno; Grabe, Magnus; Haug, Erik Skaaheim; Hellström, Pekka et al.

Part of Scandinavian Journal of Urology and Nephrology, p. 108-116, 2012

• DOI for Role of hexaminolevulinate-guided fluorescence cystoscopy in bladder cancer: critical analysis of the latest data and European guidance

Editorial

Malmström, Per-Uno

Part of Scandinavian Journal of Urology and Nephrology, p. 4-4, 2012

• DOI for Editorial

Pathologic Downstaging Is a Surrogate Marker for Efficacy and Increased Survival Following Neoadjuvant Chemotherapy and Radical Cystectomy for Muscle-Invasive Urothelial Bladder Cancer

Rosenblatt, Robert; Sherif, Amir; Rintala, Erkki; Wahlqvist, Rolf et al.

Part of European Urology, p. 1229-1238, 2012

• DOI for Pathologic Downstaging Is a Surrogate Marker for Efficacy and Increased Survival Following Neoadjuvant Chemotherapy and Radical Cystectomy for Muscle-Invasive Urothelial Bladder Cancer

Long-term follow-up after radical cystectomy with emphasis on complications and reoperations: A Swedish population-based survey

Liedberg, Fredrik; Holmberg, Erik; Holmäng, Sten; Ljungberg, Börje et al.

Part of Scandinavian Journal of Urology and Nephrology, p. 14-18, 2012

• DOI for Long-term follow-up after radical cystectomy with emphasis on complications and reoperations: A Swedish population-based survey

Cathepsin E, Maspin, Plk1, and Survivin Are Promising Prognostic Protein Markers for Progression in Non-Muscle Invasive Bladder Cancer

Fristrup, Niels; Ulhoi, Benedicte P.; Birkenkamp-Demtroder, Karin; Mansilla, Francisco et al.

Part of American Journal of Pathology, p. 1824-1834, 2012

• DOI for Cathepsin E, Maspin, Plk1, and Survivin Are Promising Prognostic Protein Markers for Progression in Non-Muscle Invasive Bladder Cancer

Analysis of molecular intra-patient variation and delineation of a prognostic 12-gene signature in non-muscle invasive bladder cancer; technology transfer from microarrays to PCR

Dyrskjot, L.; Reinert, T.; Novoradovsky, A.; Zuiverloon, T. C. M. et al.

Part of British Journal of Cancer, p. 1392-1398, 2012

• DOI for Analysis of molecular intra-patient variation and delineation of a prognostic 12-gene signature in non-muscle invasive bladder cancer; technology transfer from microarrays to PCR

Prognostic markers for urothelial cancer: Obstacles and opportunities introduction

Malmström, Per-Uno

Part of Urologic Oncology, p. 516-517, 2012

• DOI for Prognostic markers for urothelial cancer: Obstacles and opportunities introduction

Snabba åtgärder vid makrohematuri både angelägna och möjliga: [Fast measures in macro hematuria are both necessary and possible]

Liedberg, Fredrik; Holmäng, Sten; Hosseini, Abolfazl; Ljungberg, Börje et al.

Part of Läkartidningen, p. 1034-1035, 2012

Defecation disturbances after cystectomy for urinary bladder cancer

Thulin, Helena; Kreicbergs, Ulrika; Onelöv, Erik; Ahlstrand, Christer et al.

Part of BJU International, p. 196-203, 2011

• DOI for Defecation disturbances after cystectomy for urinary bladder cancer

Bladder tumours: time for a paradigm shift?

Malmström, Per-Uno

Part of BJU International, p. 1543-1545, 2011

• DOI for Bladder tumours: time for a paradigm shift?

AdCD40L Immunogene Therapy for Bladder Carcinoma: The First Phase I/IIa Trial

Malmström, Per-Uno; Loskog, Angelica S. I.; Lindqvist, Camilla A.; Mangsbo, Sara M. et al.

Part of Clinical Cancer Research, p. 3279-3287, 2010

• DOI for AdCD40L Immunogene Therapy for Bladder Carcinoma: The First Phase I/IIa Trial

Focal amplifications are associated with high grade and recurrences in stage Ta bladder carcinoma

Nord, Helena; Segersten, Ulrika; Sandgren, Johanna; Wester, Kenneth et al.

Part of International Journal of Cancer, p. 1390-1402, 2010

• DOI for Focal amplifications are associated with high grade and recurrences in stage Ta bladder carcinoma

Urinary diversion after cystectomy for bladder cancer: A population-based study in Sweden

Jahnson, Staffan; Damm, Ole; Hellsten, Sverker; Holmang, Sten et al.

Part of Scandinavian Journal of Urology and Nephrology, p. 69-75, 2010

• DOI for Urinary diversion after cystectomy for bladder cancer: A population-based study in Sweden

The star chart to Ta bladder cancer: An unsophisticated analysis of two-dimensional gel electrophoresis proteome maps

Rotterud, Ranveig; Malmström, Per-Uno; Wahlqvist, Rolf; Tasken, Kristin A.

Part of Scandinavian Journal of Urology and Nephrology, p. 76-83, 2010

• DOI for The star chart to Ta bladder cancer: An unsophisticated analysis of two-dimensional gel electrophoresis proteome maps

Bacillus Calmette-Guerin Is Superior to a Combination of Epirubicin and Interferon-alpha 2b in the Intravesical Treatment of Patients with Stage T1 Urinary Bladder Cancer. A Prospective, Randomized, Nordic Study

Duchek, Milos; Johansson, Robert; Jahnson, Staffan; Mestad, Oddvar et al.

Part of European Urology, p. 25-31, 2010

• DOI for Bacillus Calmette-Guerin Is Superior to a Combination of Epirubicin and Interferon-alpha 2b in the Intravesical Treatment of Patients with Stage T1 Urinary Bladder Cancer. A Prospective, Randomized, Nordic Study

Re: Randomized Phase III Trial on Gemcitabine Versus Mytomicin in Recurrent Superficial Bladder Cancer: Evaluation of Efficacy and Tolerance

Malmström, Per-Uno

Part of European Urology, p. 178, 2010

• DOI for Re: Randomized Phase III Trial on Gemcitabine Versus Mytomicin in Recurrent Superficial Bladder Cancer: Evaluation of Efficacy and Tolerance

Kejsarens nya kläder eller nödvändig medicinsk teknik?

Malmström, Per-Uno

Part of Läkartidningen, p. 1280-1280, 2010

High frequency of prostate antigen-directed T cells in cancer patients compared to healthy age-matched individuals

Forsberg, Ole; Carlsson, Björn; Malmström, Per-Uno; Ullenhag, Gustav et al.

Part of The Prostate, p. 70-81, 2009

• DOI for High frequency of prostate antigen-directed T cells in cancer patients compared to healthy age-matched individuals
• Download full text (pdf) of High frequency of prostate antigen-directed T cells in cancer patients compared to healthy age-matched individuals

Hygiene and urinary tract infections after cystectomy in 452 Swedish survivors of bladder cancer

Thulin, Helena; Steineck, Gunnar; Kreicbergs, Ulrika; Onelöv, Erik et al.

Part of BJU International, p. 1107-1117, 2009

• DOI for Hygiene and urinary tract infections after cystectomy in 452 Swedish survivors of bladder cancer

An individual patient data meta-analysis of the long-term outcome of randomised studies comparing intravesical mitomycin C versus bacillus Calmette-Guérin for non-muscle-invasive bladder cancer

Malmström, Per-Uno; Sylvester, Richard J.; Crawford, David E.; Friedrich, Martin et al.

Part of European Urology, p. 247-56, 2009

• DOI for An individual patient data meta-analysis of the long-term outcome of randomised studies comparing intravesical mitomycin C versus bacillus Calmette-Guérin for non-muscle-invasive bladder cancer

A novel strategy based on histological protein profiling in-silico for identifying potential biomarkers in urinary bladder cancer

Segersten, M. Ulrika; Edlund, E. Karolina; Micke, Patrick; de la Torre, Manuel et al.

Part of BJU International, p. 1780-1785, 2009

• DOI for A novel strategy based on histological protein profiling in-silico for identifying potential biomarkers in urinary bladder cancer

A population-based study of patterns of care for muscle-invasive bladder cancer in Sweden

Jahnson, Staffan; Damm, Ole; Hellsten, Sverker; Holmäng, Sten et al.

Part of Scandinavian Journal of Urology and Nephrology, p. 271-276, 2009

• DOI for A population-based study of patterns of care for muscle-invasive bladder cancer in Sweden

Fluorescence-guided transurethral resection of bladder cancer using hexaminolevulinate: analysis of health economic impact in Sweden

Malmström, Per-Uno; Hedelin, Hans; Thomas, Yngvil Kloster; Thompson, Gwilym J. et al.

Part of Scandinavian Journal of Urology and Nephrology, p. 192-198, 2009

• DOI for Fluorescence-guided transurethral resection of bladder cancer using hexaminolevulinate: analysis of health economic impact in Sweden

Impact of thawing on RNA integrity and gene expression analysis in fresh frozen tissue

Botling, Johan; Edlund, Karolina; Segersten, Ulrika; Tahmasebpoor, Simin et al.

Part of Diagnostic molecular pathology (Print), p. 44-52, 2009

• DOI for Impact of thawing on RNA integrity and gene expression analysis in fresh frozen tissue

Why has the survival of patients with bladder cancer not improved?

Malmström, Per-Uno

Part of BJU International, p. 267-9, 2008

• DOI for Why has the survival of patients with bladder cancer not improved?

Bladder cancer: pathogenesis.

Montironi, Rodolfo; Malmström, Per-Uno

Part of Scandinavian Journal of Urology and Nephrology, Supplementum, p. 93-4, 2008

• DOI for Bladder cancer: pathogenesis.

Varför negligeras smärta vid provtagning i prostata?

Malmström, Per-Uno; Ojdeby, Gunilla

Part of Läkartidningen, p. 1955, 2008

Kan läkarstudenten lära sig urologi på ett länssjukhus?: Rapport från ett IT-baserat utvecklingsprojekt på läkarprogrammet i Uppsala

Gårdmark, Truls; Heinius, Johan; Malmström, Per-Uno

Part of Läkartidningen, p. 2171-4, 2008

Chairmen's summary

Andersson, Lennart; Droller, Michael J.; Adolfsson, Jan; Månsson, Wiking et al.

Part of Scandinavian Journal of Urology and Nephrology, Supplementum, p. 7-11, 2008

• DOI for Chairmen's summary

Molecular genetics of bladder cancer: an update

Díaz de Ståhl, Teresita; Segersten, Ulrika; Malmström, Per-Uno

Part of Minerva Urologica e Nefrologica, p. 205-16, 2008

The Prognostic Role of the STK15 T91A Polymorphism and of STK15 mRNA Expression in Patients with Urothelial Cell Carcinoma

Schultz, Iman J.; Kiemeney, Lambertus A.; Roelofs, Rian; Van Aarssen, Yvonne et al.

Part of Anticancer Research, p. 1025-1030, 2007

Labelling chemistry and characterization of [90Y/177Lu]-DOTA-ZHER2:342-3 Affibody molecule, a candidate agent for locoregional treatment of urinary bladder carcinoma

Fortin, Marc-André; Orlova, Anna; Malmström, Per-Uno; Tolmachev, Vladimir

Part of International Journal of Molecular Medicine, p. 285-291, 2007

[Lu-177]pertuzumab: Experimental therapy of HER-2-expressing xenografts

Persson, Mikael; Gedda, Lars; Lundqvist, Hans; Tolmachev, Vladimir et al.

Part of Cancer Research, p. 326-331, 2007

• DOI for [Lu-177]pertuzumab: Experimental therapy of HER-2-expressing xenografts

Patient-assessed outcomes in Swedish and Egyptian men undergoing radical cystectomy and orthotopic bladder substitution--a prospective comparative study

Månsson, Åsa; Al Amin, Maaz; Malmström, Per-Uno; Wijkström, Hans et al.

Part of Urology, p. 1086-1090, 2007

• DOI for Patient-assessed outcomes in Swedish and Egyptian men undergoing radical cystectomy and orthotopic bladder substitution--a prospective comparative study

Gene expression signatures predict outcome in non-muscle-invasive bladder carcinoma: a multicenter validation study

Dyrskjøt, Lars; Zieger, Karsten; Real, Francisco X.; Malats, Núria et al.

Part of Clinical Cancer Research, p. 3545-3551, 2007

• DOI for Gene expression signatures predict outcome in non-muscle-invasive bladder carcinoma: a multicenter validation study

Analysis of progression and survival after 10 years of a randomized prospective study comparing mitomycin-C and bacillus Calmette-Guérin in patients with high-risk bladder cancer

Gårdmark, Truls; Jahnson, Staffan; Wahlquist, Rolf; Wijkström, Hans et al.

Part of BJU International, p. 817-820, 2007

• DOI for Analysis of progression and survival after 10 years of a randomized prospective study comparing mitomycin-C and bacillus Calmette-Guérin in patients with high-risk bladder cancer

Vad är bra kvalitet i prostatacancervården?

Malmström, Per-Uno

Part of Läkartidningen, p. 3021, 2007

Gene expression analysis for the prediction of recurrence in patients with primary Ta urothelial cell carcinoma

Schultz, Iman J; Wester, Kenneth; Straatman, Huub; Kiemeney, Lambertus A et al.

Part of European Urology, p. 416-423, 2007

• DOI for Gene expression analysis for the prediction of recurrence in patients with primary Ta urothelial cell carcinoma

In vitro evaluation of two polyhedral boron anion derivatives as linkers for attachment of radioiodine to the anti-HER2 monoclonal antibody trastuzumab

Persson, Mikael; Sivaev, Igor; Winberg, Karl-Johan; Gedda, Lars et al.

Part of Cancer Biotherapy and Radiopharmaceuticals, p. 585-596, 2007

• DOI for In vitro evaluation of two polyhedral boron anion derivatives as linkers for attachment of radioiodine to the anti-HER2 monoclonal antibody trastuzumab

Human bladder carcinoma is dominated by T-regulatory cells and Th1 inhibitory cytokines

Loskog, Angelica; Ninalga, Christina; Paul-Wetterberg, Gabriella; de la Torre, Manuel et al.

Part of Journal of Urology, p. 353-358, 2007

• DOI for Human bladder carcinoma is dominated by T-regulatory cells and Th1 inhibitory cytokines

Analysis of clinical characteristics, management and survival of patients with Ta T1 bladder tumours in Sweden between 1997 and 2001

Gårdmark, Truls; Bladström, Anna; Hellsten, Sverker; Malmström, Per-Uno

Part of Scandinavian Journal of Urology and Nephrology, p. 276-282, 2006

• DOI for Analysis of clinical characteristics, management and survival of patients with Ta T1 bladder tumours in Sweden between 1997 and 2001

Positron emission tomography with C11-acetate for tumor detection and localization in patients with prostate-specific antigen relapse after radical prostatectomy

Sandblom, Gabriel; Sörensen, Jens; Lundin, Niclas; Häggman, Michael et al.

Part of Urology, p. 996-1000, 2006

• DOI for Positron emission tomography with C11-acetate for tumor detection and localization in patients with prostate-specific antigen relapse after radical prostatectomy

Prediction of recurrence in Ta urothelial cell carcinoma by real-time quantitative PCR analysis: a microarray validation study

Schultz, Iman J.; Wester, Kenneth; Straatman, Huub; Kiemeney, Lambertus A. et al.

Part of International Journal of Cancer, p. 1915-1919, 2006

• DOI for Prediction of recurrence in Ta urothelial cell carcinoma by real-time quantitative PCR analysis: a microarray validation study

[Prostatic cancer--can unnecessary therapy be avoided? Prostate-specific antigens (PSA) kinetics can guide the management]

Malmström, Per-Uno

Part of Lakartidningen, p. 279, 2006

Urinary bladder cancer: hard times for evidenced-based data.

Malmstrom, Per-Uno

Part of Curr Opin Urol, p. 342-3, 2006

Optimization of the MB49 mouse bladder cancer model for adenoviral gene therapy

Loskog, Angelica; Ninalga, Christina; Hedlund, Titti; Alimohammadi, Mohammad et al.

Part of Laboratory Animals, p. 384-393, 2005

• DOI for Optimization of the MB49 mouse bladder cancer model for adenoviral gene therapy

EGF-receptor targeted liposomes with boronated acridine: growth inhibition of cultured glioma cells after neutron irradiation

Kullberg, Erika Bohl; Wei, Qichun; Capala, Jacek; Giusti, Valerio et al.

Part of International Journal of Radiation Biology, p. 621-629, 2005

• DOI for EGF-receptor targeted liposomes with boronated acridine: growth inhibition of cultured glioma cells after neutron irradiation

Analysis of HER2 expression in primary urinary bladder carcinoma and corresponding metastases

Gårdmark, Truls; Wester, Kenneth; De la Torre, Manuel; Carlsson, Jörgen et al.

Part of BJU International, p. 982-986, 2005

• DOI for Analysis of HER2 expression in primary urinary bladder carcinoma and corresponding metastases

Lymph node staging in prostatic carcinoma revisited.

Malmström, Per-Uno

Part of Acta Oncol, p. 593-8, 2005

Low-grade Ta (noninvasive) urothelial carcinoma of the bladder.

Oosterlinck, Willem; Solsona, Eduardo; Akaza, Hideyuki; Busch, Christer et al.

Part of Urology, p. 75-89, 2005

Randomized phase II marker lesion study evaluating effect of scheduling on response to intravesical gemcitabine in recurrent Stage Ta urothelial cell carcinoma of the bladder.

Gårdmark, Truls; Carringer, Malcolm; Beckman, Eva; Malmström, Per-Uno

Part of Urology, p. 527-30, 2005

[No evidence that lowered PSA reference levels will help us detect those cases of prostatic cancer that will lead to morbidity and mortality]

Malmström, Per-Uno

Part of Lakartidningen, 2005

Results of second-look resection after primary resection of T1 tumour of the urinary bladder.

Jahnson, Staffan; Wiklund, Fredrik; Duchek, Milos; Mestad, Oddvar et al.

Part of Scand J Urol Nephrol, p. 206-10, 2005

Radiobromination of anti-HER2/neu/ErbB-2 monoclonal antibody using the p-isothiocyanatobenzene derivative of the [76Br]undecahydro-bromo-7,8-dicarba-nido-undecaborate(1-) ion

Winberg, Karl Johan; Persson, Mikael; Malmström, Per-Uno; Sjöberg, Stefan et al.

Part of Nuclear Medicine and Biology, p. 425-33, 2004

• DOI for Radiobromination of anti-HER2/neu/ErbB-2 monoclonal antibody using the p-isothiocyanatobenzene derivative of the [76Br]undecahydro-bromo-7,8-dicarba-nido-undecaborate(1-) ion

Neoadjuvant cisplatinum based combination chemotherapy in patients with invasive bladder cancer: a combined analysis of two Nordic studies.

Sherif, Amir; Holmberg, Lars; Rintala, Erkki; Mestad, Oddvar et al.

Part of Eur Urol, p. 297-303, 2004

HER-2, EGFR, COX-2 expression status correlated to microvessel density and survival in resected non-small cell lung cancer.

Brattström, Daniel; Wester, Kenneth; Bergqvist, Michael; Hesselius, Patrik et al.

Part of Acta Oncol, p. 80-6, 2004

Zinc-based fixative improves preservation of genomic DNA and proteins in histoprocessing of human tissues.

Wester, Kenneth; Asplund, Anna; Bäckvall, Helena; Micke, Patrick et al.

Part of Lab Invest, p. 889-99, 2003

HER-2: A possible target for therapy of metastatic urinary bladder carcinoma

Wester, Kenneth; Sjöström, Anna; de la Torre, Manuel; Carlsson, Jörgen et al.

Part of Acta Oncologica, p. 282-288, 2002

• DOI for HER-2: A possible target for therapy of metastatic urinary bladder carcinoma

Human urinary bladder carcinomas express adenovirus attachment and internalization receptors

Loskog, Angelica; Hedlund, Titti; Wester, Kenneth; de la Torre, Manuel et al.

Part of Gene Therapy, p. 547-553, 2002

• DOI for Human urinary bladder carcinomas express adenovirus attachment and internalization receptors

Conjugate chemistry and cellular processing of EGF-dextran

Carlsson, Jörgen; Blomquist, Erik; Gedda, Lars; Liljegren, Åsa et al.

Part of Acta Oncologica, p. 313-321, 1999

Trends in urinary bladder cancer incidence in Sweden 1960-93 with special reference to histopathology, time period, birth cohort, and smoking

Thörn, Magnus; Bergström, Reinhold; Johansson, Anna-Maria; Ramström, Lars et al.

Part of Cancer Causes & Control, p. 560-567, 1997

Blue light flexible cystoscopy with hexaminolevulinate in non-muscle-invasive bladder cancer: review of the clinical evidence and consensus statement on optimal use in the USA - update 2018

Lotan, Yair; Bivalacqua, Trinity J.; Downs, Tracy; Huang, William et al.

Part of Nature reviews. Urology, p. 377-386, 2019

• DOI for Blue light flexible cystoscopy with hexaminolevulinate in non-muscle-invasive bladder cancer: review of the clinical evidence and consensus statement on optimal use in the USA - update 2018
• Download full text (pdf) of Blue light flexible cystoscopy with hexaminolevulinate in non-muscle-invasive bladder cancer: review of the clinical evidence and consensus statement on optimal use in the USA - update 2018

Non-muscle-invasive bladder cancer: a vision for the future

Malmström, Per-Uno; Agrawal, Sachin; Blackberg, Mats; Boström, Peter J. et al.

Part of Scandinavian journal of urology, p. 87-94, 2017

• DOI for Non-muscle-invasive bladder cancer: a vision for the future

Bladder cancer

Kamat, Ashish M; Hahn, Noah M; Efstathiou, Jason A; Lerner, Seth P et al.

Part of The Lancet, p. 2796-2810, 2016

• DOI for Bladder cancer

Molecular Markers for Bladder Cancer Screening, Early Diagnosis, and Surveillance: The WHO/ICUD Consensus

Schmitz-Draeger, Bernd J.; Droller, Michael; Lokeshwar, Vinata B.; Lotan, Yair et al.

Part of Urologia internationalis, p. 1-24, 2015

• DOI for Molecular Markers for Bladder Cancer Screening, Early Diagnosis, and Surveillance: The WHO/ICUD Consensus

An overview on preclinical and clinical experiences with photodynamic therapy for bladder cancer

Yavari, Nazila; Andersson-Engels, Stefan; Segersten, Ulrika; Malmström, Per-Uno

Part of Canadian Journal of Urology, p. 5778-5786, 2011

The Role of Bacillus Calmette-Guerin in the Treatment of Non-Muscle-Invasive Bladder Cancer

Gontero, Paolo; Bohle, Andreas; Malmström, Per-Uno; O'Donnell, Michael A. et al.

Part of European Urology, p. 410-429, 2010

• DOI for The Role of Bacillus Calmette-Guerin in the Treatment of Non-Muscle-Invasive Bladder Cancer

Hexaminolevulinate-Guided Fluorescence Cystoscopy in the Diagnosis and Follow-Up of Patients with Non-Muscle-Invasive Bladder Cancer: Review of the Evidence and Recommendations

Witjes, J. Alfred; Palou Redorta, Juan; Jacqmin, Didier; Sofras, Frank et al.

Part of European Urology, p. 607-614, 2010

• DOI for Hexaminolevulinate-Guided Fluorescence Cystoscopy in the Diagnosis and Follow-Up of Patients with Non-Muscle-Invasive Bladder Cancer: Review of the Evidence and Recommendations

Galectin-1, a potential therapeutic target, in primary tumors and metastases of urinary bladder carcinomas

Lindén, Mårten; Hemdan, Tammer; Ugge, Henrik; Bergström Lind, Sara et al.

2013

Stathmin-1 is a promising prognostic factor and potential therapeutic target in urinary bladder cancer

Hemdan, Tammer; Lindén, Mårten; Bergström Lind, Sara; Namuduri, Arvind Venkat et al.

The tumour microenvironment across tumour evolution in bladder cancer profiled by single-cell RNA-sequencing analysis and spatial transcriptomics

Kostakis, Alexandros; Beháňová, Andrea; Kyriaki Kerzeli, Iliana; Elgendy, Ramy et al.